Clinical Research Services
- Clinical Development
- Phase II-III Registrational Trials
- Long-Term Safety Programs
- Expanded Access Programs
- Global Site Management
- Risk-Based Clinical Monitoring
- Patient and Physician Recruitment & Retention
- Data Management & Biostatistics
- Regulatory Writing Services
- Quality Assurance
- Innovative Technology Platforms
- Clinical Trial Support - Home Health Nurses
Late Stage Research
- Peri & Postapproval
- Phase IIIb -IV
- Postmarketing Requirements (PMR)
- Post Approval Safety Studies (PASS)
- Market Access & Value Demonstration
- Burden and Cost-of-Illness Studies
- Retrospective Chart Review
- Prospective Evaluation of HEOR End-Points
- Time & Motion
- Real-World Data Analytics
As a global clinical research organization (CRO), UBC offers a range of clinical development and late stage clinical research services, including clinical trial implementation and management, patient recruitment, peri and postapproval studies, registries, and value demonstration studies. We are focused on helping pharmaceutical and biotech sponsors generate real-world evidence to obtain regulatory approval.
UBC is a leader in safety data collection and reporting for both clinical trial and post-marketing studies. We also offer risk based monitoring, clinical risk management, Risk Evaluation and Mitigation Strategies (REMS) and Risk Management Plans (RMPs). Our global pharmacovigilance team provides comprehensive global safety and medical services, including safety case management, medical safety and writing, signal detection and surveillance. We help pharmaceutical and biotech manufacturers maximize product performance by managing risk before, during, and after launch.
UBC helps patients and physicians maneuver the administrative obstacles to therapy and build product loyalty while effectively managing health coverage. Our Reimbursement Hub services cover a thorough process of benefit investigations, prior authorizations, and appeals, and are tailored to each product and disease state. Building on the HealthBridge legacy of expertise in Patient Assistance Programs, we also design and manage patient assistance services that provide prescription asssistance for uninsured and underinsured patients.
UBC offers robust adherence support programs designed to enhance patients’ therapeutic journeys. Pharmaceutical manufacturers can tap into our nursing network, which provides clinical support to patients throughout the United States and Europe. Our nurses are experts in the therapeutic area they support and perform a variety of functions, including telephonic support and patient education through our Clinical Support Centers, Site of Care administration, injection training, and administration of complex specialty products. They play a key role in our custom medication adherence programs, which lead to better adherence, increased utilization, and improved patient outcomes.
UBC partners with Accredo® Specialty Pharmacy and CuraScript® Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.